Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.58 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.58 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.32 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26624063 | 1.00 | AKR1C4 (0.58) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL10941968 | 1.00 | AKR1C4 (0.58) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL2948165 | 1.00 | AKR1C4 (0.58) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| Acetic Acid SCHEMBL57726 | 0.92 | AKR1C4 (0.62) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL26626337 | 0.81 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL19604584 | 0.81 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL19604624 | 0.81 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL14373673 | 0.81 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL21383060 | 0.80 | AKR1C4 (0.56) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL9842994 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10086392-B2 | Dispensers for dispensing microcapsules | THE PROCTER & GAMBLE COMPANY (US) | 2018-10-02 | — | — | US | disclosed |
| EP-3151869-B1 | KIT FOR PROVIDING LONG LASTING FRAGRANCES | PROCTER & GAMBLE (US) | 2018-09-12 | — | — | EP | disclosed |
| EP-3151972-B1 | FLUSHING DISPENSERS FOR DELIVERING A CONSISTENT CONSUMER EXPERIENCE | PROCTER & GAMBLE (US) | 2018-07-25 | — | — | EP | disclosed |
| EP-3151977-B1 | FLUSHING DISPENSERS FOR DELIVERING A CONSISTENT CONSUMER EXPERIENCE | PROCTER & GAMBLE (US) | 2018-07-25 | — | — | EP | disclosed |
| EP-3347137-A1 | DISPENSERS FOR DISPENSING MICROCAPSULES | The Procter and Gamble Company (US) | 2018-07-18 | — | — | EP | disclosed |
| EP-3347136-A1 | DISPENSERS FOR DISPENSING MICROCAPSULES | The Procter and Gamble Company (US) | 2018-07-18 | — | — | EP | disclosed |
| US-20180126400-A1 | Flushing Dispensers for Delivering a Consistent Consumer Experience | THE PROCTER & GAMBLE COMPANY | 2018-05-10 | — | — | US | disclosed |
| US-9925550-B2 | Articles providing long lasting fragrances | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-27 | — | — | US | disclosed |
| US-20170368563-A1 | Dispensers for Dispensing Microcapsules | THE PROCTER & GAMBLE COMPANY | 2017-12-28 | — | — | US | disclosed |
| US-9839931-B2 | Dispensers for dispensing microcapsules | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-12 | — | — | US | disclosed |
| US-20150352576-A1 | Dispensers For Delivering A Consistent Consumer Experience | THE PROCTER & GAMBLE COMPANY | 2015-12-10 | — | — | US | disclosed |
| EP-2366014-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2015-11-04 | — | — | EP | disclosed |
| US-8754028-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-17 | — | — | US | disclosed |
| EP-2366014-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2011-09-21 | — | — | EP | disclosed |
| US-20100152083-A1 | Perfume Systems | PROCTER & GAMBLE COMPANY, THE | 2010-06-17 | — | — | US | disclosed |
| US-20100113460-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
| EP-2139354-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2010-01-06 | — | — | EP | disclosed |
| WO-2009027957-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2009-03-05 | — | — | WO | disclosed |
| US-20090018021-A1 | Methyl jasmonate decreases fruit detachment force of grapes | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-01-15 | — | — | US | disclosed |
| WO-2008116339-A2 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018021-A1 | Methyl jasmonate decreases fruit detachment force of grapes | MYB, JMJD1C, VIM | AKR1C4 3313/4885AKR1C3 3273/4885AKR1C2 3181/4885 |
| US-20100113460-A1 | Organic Compounds | CYP2B6, CYP2A6, CYP2A13 | AKR1C4 291/4885AKR1C3 330/4885AKR1C2 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.